194 related articles for article (PubMed ID: 31501225)
1. N-glycopeptide Signatures of IgA
Zhang S; Cao X; Liu C; Li W; Zeng W; Li B; Chi H; Liu M; Qin X; Tang L; Yan G; Ge Z; Liu Y; Gao Q; Lu H
Mol Cell Proteomics; 2019 Nov; 18(11):2262-2272. PubMed ID: 31501225
[TBL] [Abstract][Full Text] [Related]
2. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J
Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
5. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
6. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
8. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
10. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
11. Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients.
Quoc NB; Phuong NDN; Ngan TK; Linh NTM; Cuong PH; Chau NNB
Microrna; 2018; 7(2):92-99. PubMed ID: 29701140
[TBL] [Abstract][Full Text] [Related]
12. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
13. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
[TBL] [Abstract][Full Text] [Related]
14. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma.
Kaji H; Ocho M; Togayachi A; Kuno A; Sogabe M; Ohkura T; Nozaki H; Angata T; Chiba Y; Ozaki H; Hirabayashi J; Tanaka Y; Mizokami M; Ikehara Y; Narimatsu H
J Proteome Res; 2013 Jun; 12(6):2630-40. PubMed ID: 23586699
[TBL] [Abstract][Full Text] [Related]
16. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
[TBL] [Abstract][Full Text] [Related]
17. [Difference of HBV DNA levels and HBV genotypes between the patients with primary hepatocellular carcinoma and liver cirrhosis with hepatitis B].
Wang JH; Zhou M; Li Y; Deng J; Wu XX; Cheng W; Gu XB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):245-7. PubMed ID: 22097598
[TBL] [Abstract][Full Text] [Related]
18. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
[TBL] [Abstract][Full Text] [Related]
19. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
20. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
